TransMedics Group Inc. share price logo

TransMedics Group Inc.

NASDAQ: TMDX

Mid Cap

$78.79

+5.57

(+7.61%)

as on

TransMedics Group Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $75.12
    $80.72
    downward going graph

    4.66%

    Downside

    2.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $60.11
    $156.00
    downward going graph

    23.71%

    Downside

    97.99%

    Upside

    downward going graph

TransMedics Group Inc. share price movements today

Previous Close
$73.22
Open
$75.48
Volume
1.1M
Day's Low - High
$75.12 - $80.72
52 Week Low - High
$60.11 - $156.00

TransMedics Group Inc. Historical Returns

1 Month Return
+ 19.14 %
3 Month Return
-30.72 %
1 Year Return
-36.46 %
3 Year Return
+ 0.2 %
5 Year Return
+ 164.57 %

TransMedics Group Inc. Stock Fundamentals & Key Indicators

Check TransMedics Group Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5B

EPS (TTM)

2.0452

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.71%

PE Ratio (TTM)

16.76

Industry PE ratio

18.255454545454544

PEG Ratio

0

EBITDA

125.3M

Revenue (TTM)

635.9M

Profit Margin

27.04%

Return On Equity TTM

45.22%

TransMedics Group Inc. Stock Valuation

Track how TransMedics Group Inc. P/E has moved over time to understand its valuation trends.

TransMedics Group Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-134.30x)

June 30, 2023

Today (16.76x)

June 19, 2026

Industry (18.26x)

June 19, 2026

Highest (163.92x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 16.76x

TransMedics Group Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TransMedics Group Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
TransMedics Group Inc. image
TransMedics Group Inc.
BUY$2.5B164.57%16.7627.04%NA
Stryker Corporation image
Stryker Corporation
BUY$115.4B20.75%34.8913.21%1.11%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$49.9B-13.26%46.8517.39%NA
Medtronic plc image
Medtronic plc
BUY$100.3B-35.62%20.7313.20%3.49%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$66.8B5.28%18.8117.29%NA
See all

Stock Returns calculator for TransMedics Group Inc. Stock including INR - Dollar returns

The TransMedics Group Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

TransMedics Group Inc. investment value today

Current value as on today

₹69,213

Returns

-₹30,787

(-30.79%)

Returns from TransMedics Group Inc. Stock

-₹36,460 (-36.46%)

Dollar Impact

₹5,673 (+5.67%)

Analyst Recommendation on TransMedics Group Inc. Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for TransMedics Group Inc.. Average target price of $116.78

TransMedics Group Inc. Share Price Target

Get share price movements and forecasts by analysts on TransMedics Group Inc..

What analysts predicted

32.53%UPSIDE

Target Price

$116.78

Current Price

$78.79

Analyzed by

13 Analysts

Target

$116.78

TransMedics Group Inc. target price $116.78, a slight upside of 32.53% compared to current price of $78.79. According to 13 analysts rating.

Indian Investors' Interest in TransMedics Group Inc. Stock

Investment in TransMedics Group Inc. Shares on INDmoney has dropped by -57.11% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-57.11% versus previous 30 day period

Search interest for TransMedics Group Inc. Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

TransMedics Group Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
81
96
114
108
121
143
157
143
160
173
Gross Profit
47
59
69
60
72
88
96
84
93
101
Operating Income
2
12
12
3
8
27
36
23
21
13
EBITDA
11
20
20
13
16
36
46
33
32
27
Interest Expense
3
3
3
3
3
3
3
3
3
7
Depreciation
3
4
4
5
5
6
6
6
7
11
Income Before Tax
3
12
12
4
6
26
36
23
21
8
Income Tax Expense
0
0
0
0
0
0
1
-1
-83
1
Net Income
4
12
12
4
6
25
34
24
105
7
Net Profit Margin
4.97%
12.59%
10.67%
3.88%
5.64%
17.89%
22.18%
16.91%
65.55%
4.21%

TransMedics Group Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
13
23
25
30
93
241
441
605
Gross Profit
0
2
5
13
16
21
65
154
262
362
Operating Income
-22
-20
-20
-29
-26
-39
-31
-28
37
108
EBITDA
-22
-19
-20
-27
-23
-38
-28
-7
69
148
Interest Expense
0
1
2
4
3
3
3
10
14
13
Depreciation
-
0
0
1
1
1
3
5
19
27
Income Before Tax
-24
-20
-23
-33
-28
-44
-36
-26
35
107
Income Tax Expense
0
0
0
0
0
0
0
-1
0
-82
Net Income
-24
-20
-23
-33
-28
-44
-36
-25
35
190
Net Profit Margin
-387.58%
-270.96%
-182.50%
-142.12%
-112.13%
-146.11%
-38.77%
-10.36%
8.03%
31.43%

TransMedics Group Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
12
12
4
6
25
34
24
105
7
Operating Cash Flow
-3
25
6
19
-2
91
69
34
24
Investing Cash Flow
-44
-23
-47
-13
-27
-9
-7
-15
-36
Financing Cash Flow
3
10
7
1
3
7
3
3
3
Change in Cash
-44
12
-32
6
-26
90
65
22
-8

TransMedics Group Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-23
-33
-28
-44
-36
-25
35
190
Operating Cash Flow
-23
-25
-32
-30
-28
-45
-13
48
192
Investing Cash Flow
24
12
-60
-41
29
54
-193
-129
-59
Financing Cash Flow
0
22
92
75
1
167
400
22
16
Change in Cash
2
8
0
4
0
175
193
-58
151

Global Institutional Holdings in TransMedics Group Inc.

Funds
Holdings
Eventide Asset Management, LLC
1.59%
Two Sigma Investments LLC
1.26%
Wellington Management Company LLP
1.41%
BlackRock Inc
15.32%
Delaware Management Holdings Inc
2.56%
See all

TransMedics Group Inc. News & Key Events

  • img

    Today's Timeline - 08 March

    Sun, 01:45 PM

    -

    TransMedics reports 2025 revenue of $605.5 million, a 37% increase, with OCS Liver accounting for 36% of U.S. transplants.

    Mon, 03:40 AM

    -

    TransMedics Group faces short-term share price decline despite strong long-term performance and fundamentals.

Insights on TransMedics Group Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TMDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TMDX stock has moved up by 8.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 143.82M → 173.93M (in $), with an average increase of 9.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 18.3% return, outperforming this stock by 54.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 105.38M → 7.31M (in $), with an average decrease of 93.1% per quarter

About TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
OrganisationTransMedics Group Inc.
Headquarters200 Minuteman Road, Andover, MA, United States, 01810
IndustryMedical Devices
CEODr. Waleed H. Hassanein M.D.
E-voting on sharesClick here to vote

Key Management of TransMedics Group Inc.

Name

Title

Mr. Gerardo Hernandez

CFO & Treasurer

Mr. Nicholas Corcoran

Senior Vice President of Supply Chain & Operations

Dr. Tamer I. Khayal M.D.

Senior Vice President of International

Mr. Anil Ranganath

Advisor

Mr. Matthew Forsyth

Senior VP, General Counsel & Corporate Secretary

Ms. Miriam C. Provost Ph.D.

Vice President of Global Regulatory Affairs

Dr. Waleed H. Hassanein M.D.

Founder, President, CEO & Director

FAQs

What is TransMedics Group Inc. share price today?

TransMedics Group Inc. share price today is $78.79 as on at the close of the market. TransMedics Group Inc. share today touched a day high of $80.72 and a low of $75.12.

What is the 52 week high and 52 week low for TransMedics Group Inc. share?

TransMedics Group Inc. share touched a 52 week high of $156 on and a 52 week low of $60.11 on . TransMedics Group Inc. stock price today i.e. is closed at $78.79,which is 49.49% down from its 52 week high and 31.09% up from its 52 week low.

What is TransMedics Group Inc.'s market capitalisation today?

TransMedics Group Inc. market capitalisation is $0.00T as on .

How to invest in TransMedics Group Inc. Stock (TMDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TransMedics Group Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TransMedics Group Inc. Shares that will get you 0.0190 shares as per TransMedics Group Inc. share price of $78.79 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy TransMedics Group Inc. Stock (TMDX) from India?

Indian investors can start investing in TransMedics Group Inc. (TMDX) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in TransMedics Group Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on TransMedics Group Inc. share’s latest price of $78.79 as on June 19, 2026 at 8:46 am IST, you will get 0.1269 shares of TransMedics Group Inc.. Learn more about fractional shares .

What are the returns that TransMedics Group Inc. has given to Indian investors in the last 5 years?

TransMedics Group Inc. stock has given 164.57% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?